跳至主要内容
临床试验/NCT00315146
NCT00315146已完成4 期

Optimizing Body Composition for Function in Older Adults (OPTIMA) - A Pepper Pilot Study

Wake Forest University Health Sciences1 个研究点 分布在 1 个国家目标入组 88 人开始时间: 2006年4月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
4 期
状态
已完成
入组人数
88
试验地点
1
主要终点
Appendicular Non-bone Lean Mass

研究概览

简要总结

The purpose of this pilot study is to compare two strategies intended to improve the health of overweight older adults by improving body composition. One strategy, resistance training, is designed to preserve skeletal muscle mass. The other strategy, the use of a PPAR-γ agonist, is designed to enhance the loss of fat from visceral and skeletal depots. These strategies will be used in conjunction with a hypocaloric diet and will be compared to a hypocaloric diet alone to determine if either of these strategies are superior in reducing visceral fat and preserving muscle mass.

详细描述

In this pilot we propose to recruit 88 older (65 - 79 yrs) men (n=48) and women (n=40) at risk for disability and with indications for weight loss according to NIH guidelines. All will be enrolled in a dietary intervention designed to generate a caloric deficit of 500 kcal/day for a 4 month period. All will receive supplemental vitamin D and calcium. These participants will be randomized into one of 4 groups:

Group 1 - Hypocaloric diet (and placebo) Group 2 - Hypocaloric diet and resistance training designed to maximize muscular power (and placebo) Group 3 - Hypocaloric diet and a PPAR- γ agonist (pioglitazone/Actos™) Group 4 - Hypocaloric diet and resistance training and pioglitazone/Actos™

The specific aims of the pilot are:

  1. In both men and women, to determine whether randomization to resistance exercise is associated with an increased retention of appendicular non-bone lean mass compared to those not undergoing power training.
  2. In both men and women, to determine whether randomization to the pioglitazone group is associated with an increased loss of visceral adiposity relative to randomization to the non-pioglitazone group.
  3. Assess the feasibility of the recruitment, assessment and intervention strategies
  4. To estimate adherence to the weight loss, exercise training, and drug interventions;
  5. In this population, to determine measurement characteristics of the functional outcomes that will be considered as primary end-points of the larger study.
  6. To obtain pilot data on a subset of participants to determine the feasibility, acceptability and measurement characteristics of muscle samples (biopsies) to quantify intramyocellular lipid in this study population.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Factorial
主要目的
Treatment
盲法
Single (Participant)

入排标准

年龄范围
65 Years 至 79 Years(Older Adult)
性别
All
接受健康志愿者

入选标准

  • Weight Stable, Indication for weight loss per NIH guidelines, Performance on the short physical performance battery score 3-10

排除标准

  • Diabetes, weight > 136 kg, Medical condition that limits exercise participation, Congestive heart failure, abnormal kidney function, higher ALT than normal, currently involved in a weight loss or exercise program, current smoking, alcohol or drug abuse, taking anti-inflammatory steroids, taking protein supplements, taking PPAR-gamma agonist, edema, anemia

研究组 & 干预措施

Hypocaloric diet (and placebo)

Placebo Comparator

干预措施: Hypocaloric diet (Behavioral)

Hypocaloric diet (and placebo)

Placebo Comparator

干预措施: Placebo (Drug)

Hypocaloric diet, resist. training to maximize power, placebo

Active Comparator

干预措施: Resistance exercise training to maximize muscle power (Behavioral)

Hypocaloric diet, resist. training to maximize power, placebo

Active Comparator

干预措施: Hypocaloric diet (Behavioral)

Hypocaloric diet, resist. training to maximize power, placebo

Active Comparator

干预措施: Placebo (Drug)

Hypocaloric diet and a PPAR- γ agonist (pioglitazone/Actos™)

Active Comparator

干预措施: Pioglitazone (Drug)

Hypocaloric diet and a PPAR- γ agonist (pioglitazone/Actos™)

Active Comparator

干预措施: Hypocaloric diet (Behavioral)

Hypocaloric diet,resistance training, pioglitazone/Actos™

Active Comparator

干预措施: Pioglitazone (Drug)

Hypocaloric diet,resistance training, pioglitazone/Actos™

Active Comparator

干预措施: Resistance exercise training to maximize muscle power (Behavioral)

Hypocaloric diet,resistance training, pioglitazone/Actos™

Active Comparator

干预措施: Hypocaloric diet (Behavioral)

结局指标

主要结局

Appendicular Non-bone Lean Mass

时间窗: Baseline visit (pre intervention) and 4month follow up (post intervention)

Change in Appendicular Non-bone Lean Mass

次要结局

  • Lean Body Mass(Baseline visit (pre intervention) and 4month follow up (post intervention))

研究者

申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验

Optimizing Body Composition for Function in Older... | 临床试验